TY  - JOUR 
AU  - Stuurman, A.L.
AU  - Carmona, A.
AU  - Biccler, J.
AU  - Descamps, A.
AU  - Levi, M.
AU  - Baum, U.
AU  - Mira-Iglesias, A.
AU  - Bellino, S.
AU  - Hoang, U.
AU  - Lusignan, S.D.
AU  - Bonaiuti, R.
AU  - Lina, B.
AU  - Rizzo, C.
AU  - Nohynek, H.
AU  - Diez Domingo, Javier
PY  - 2023
SN  - 2296-2565
UR  - http://hdl.handle.net/20.500.11940/21166
AB  - Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public...
LA  - eng
KW  - Adult
KW  - Aged
KW  - Child
KW  - Humans
KW  - Cohort Studies
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Europe
KW  - Influenza Vaccines
KW  - Influenza, Human
KW  - Seasons
KW  - Vaccine Efficacy
KW  - Male
KW  - Female
KW  - Adolescent
KW  - Young Adult
KW  - Middle Aged
TI  - Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform
DO  - 10.3389/fpubh.2023.1195409
T2  - Frontiers in Public Health
KW  - AS Santiago
KW  - IDIS
VL  - 11
ER  -